Xiaoke Liu

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC

Yongsheng Wang, Yi Li, P. Shu, 2019, Scientific Reports.

Bisphosphonates enhance EGFR-TKIs efficacy in advanced NSCLC patients with EGFR activating mutation: A retrospective study

P. Yu, You Lu, Jin Zhou, 2015, Oncotarget.

Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3.

Yang Du, Tao Yin, Yongsheng Wang, 2015, International journal of oncology.

Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?

Yan Zhang, Yuan Tang, Yuqan Wei, 2013, Lung cancer.

[REGgamma promotes malignant behaviors of lung cancer cells].

S. Luo, Qing Qin, Xiao-yu Li, 2014, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3.

Yang Du, Tao Yin, Yongsheng Wang, 2015, International journal of oncology.